ATOSSA THERAPEUTICS, INC.·4

Jun 20, 8:15 PM ET

WEAVER GREGORY L 4

4 · ATOSSA THERAPEUTICS, INC. · Filed Jun 20, 2023

Insider Transaction Report

Form 4
Period: 2023-06-20
Transactions
  • Purchase

    Common Stock

    2023-06-20$0.97/sh+50,000$48,50050,055 total
Footnotes (2)
  • [F1]The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.99. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
  • [F2]Includes shares of common stock purchased on November 21, 2013, which were previously reported on a Form 4 filed by the Reporting Person on November 22, 2013 but erroneously omitted in subsequent filings.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4